Rang	Name	Position
1	Mr. Jason A. Okazaki J.D.	CEO, President & Director
2	Dr. William E. Delaney IV, Ph.D.	Chief Scientific Officer
3	Dr. Anuj Gaggar M.D., Ph.D.	Chief Medical Officer
4	Ms. Jeanette M. Bjorkquist	Principal Financial Officer, Executive Director of Accounting & Treasury
5	Mr. Shannon Ryan	Senior Vice President of Investor Relations, Corporate Affairs & Alliance Management
6	Ms. Jennifer A. Troia MHROD, SHRM-SCP, SPHR	Chief Human Resources Officer
7	Dr. Nicole S. White Ph.D.	Chief Manufacturing Officer
8	Ms. Katie Kitrinos	Senior VP of Preclinical Research & Development
9	Mr. Thomas E. Rollins	Executive Officer
10	Amy Figueroa C.F.A.	Investor Relations Consultant

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Paradigm Biocapital Advisors LP	7,83%	47,49 Mio. USD
2	Farallon Capital Management, L.L.C.	6,18%	37,52 Mio. USD
3	RA Capital Management, LLC	5,14%	31,19 Mio. USD
4	COMMODORE CAPITAL LP	5,04%	30,57 Mio. USD
5	HHG PLC	4,28%	25,96 Mio. USD
6	Parkman Healthcare Partners LLC	3,63%	22,04 Mio. USD
7	Vanguard Capital Management, LLC	2,47%	14,99 Mio. USD
8	StemPoint Capital LP	1,87%	11,34 Mio. USD
9	Point72 Asset Management, L.P.	1,73%	10,52 Mio. USD
10	Millennium Management LLC	1,51%	9,13 Mio. USD
11	Blackstone Inc	1,50%	9,07 Mio. USD
12	Aberdeen Group PLC	1,04%	6,33 Mio. USD
13	BlackRock Inc	1,02%	6,20 Mio. USD
14	Affinity Asset Advisors, LLC	0,96%	5,81 Mio. USD
15	B Group, Inc	0,89%	5,37 Mio. USD
16	Marshall Wace Asset Management Ltd	0,82%	5,00 Mio. USD
17	Squadron Capital Management LLC	0,81%	4,89 Mio. USD
18	Ally Bridge Group (NY) LLC	0,71%	4,28 Mio. USD
19	Geode Capital Management, LLC	0,67%	4,07 Mio. USD
20	Schonfeld Strategic Advisors LLC	0,61%	3,68 Mio. USD